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Abstract
The associations between physical activity, demographic, and health-related
characteristics and 5-year mortality were studied using the National Health and
Nutrition Examination Survey (NHANES). Forward selection revealed that age,
smoking status, drinking status, gender, comorbidity information including whether
the person has CHF, cancer, stroke or diabetes at current age, blood pressure dif-
ference, and one fragmentation metric that quantifies the frequency of transition-
ing from active to sedentary are the most predictive predictors for 5-year all-cause
mortality. These risk factors were used to build a prediction model, which has a
10-fold cross-validated AUC equal to 0.828. Our competing risk analyses for heart
disease and cancer related deaths provided further insights into cause-specific pre-
dictors. In general, the results are consistent with our findings when all cause mor-
tality is of concern, however, there are discrepancies which might be due to the
decrease in number of events from all cause to cause specific mortality data. We
conducted an upstrap re-sampling analysis to evaluate the effect of sample size
and event per variable(EPV) on the power to detect the significances of regression
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coefficients. In general, the power to detect the significant effect for each covariate
goes up as the sample size and EPV increases. Moreover, we built a Shiny APP to
translate our work to the general public. In conclusion, our research demonstrates
the beneficial health effects of physical activity, non-smoking, and moderate drink-
ing.
Primary Reader: Ciprian Crainiceanu
Secondary Reader: Mei Cheng Wang
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The National Health and Nutrition Examination Survey (NHANES) is a cross-
sectional, nationally representative survey designed to evaluate the health and nu-
tritional status of adults and children in the United States [2]. The survey samples
around 5000 non-institutionalized civilians annually to represent the US popula-
tion. In particular, NHANES oversamples underrepresented groups, including
elderly people 60+ years old, African American, Asian, and Hispanic. The survey
involves a 4-stage process to sample participants, which indicates that the sample
is not a simple random sample from the US population. To make the sample rep-
resentative for the US population each individual sampled in the NHANES has a
survey weight, which is defined as the number of individuals in the US popula-
tion represented by that individual. These survey weights need to be incorporated
in any analysis to ensure that results are generalizable to the US population. The
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CHAPTER 1. INTRODUCTION
survey collects demographic, socioeconomic, dietary, and health-related informa-
tion through home interviews, and medical, dental, physiological measurements
through physical examinations in mobile centers[2]. Moreover, NHANES started
to monitor participants’ physical activity through accelerometer during a 1-week
study for its 2003-2004 and 2005-2006 cohorts. The National Center for Health
Statistics also provides a mechanism for linking NHANES waves with death cer-
tificate records from the National Death Index (NDI)[9]. This allows us to investi-
gate the associations between participants’ activity and other non-activity related
characteristics and future mortality.
For our research, we are interested in: 1) exploring the associations between
participants’ physical activity, demographic, and health-related characteristics and
5-year mortality; 2) identifying the ranking of the most predictive predictors and
their relative effects on mortality; and 3) and building prediction models to pre-
dict 5-year mortality. The prediction model was developed into a Shiny APP
(https://yezheng42.shinyapps.io/MortalityCalculator/) that takes users’ in-
put about their demographic, physical activity, and health-related information,
and then predict user’s 5-year all-cause mortality and relative risk of death as
compared with a reference individual . Users can change modifiable health risk
behaviors and see how it impacts their predicted mortality over time. The APP
has the potential to translate our research work to the general public, and it also
provides translational individualized advice. In addition to the overall mortality,
2
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we have also examined the associations between participants’ physical activity, de-
mographic, and health-related characteristics with heart disease-specific mortality
and cancer-specific mortality through competing risk models.
The paper is structured as follows: In Chapter 2, we will briefly introduce the
NHANES dataset and the accelerometer metrics we derived. In Chapter 3, we
present some exploratory plots to investigate the associations between physical ac-
tivity and mortality, correlations between activity metrics, and the potential modi-
fying effect of age on the association between physical activity and 5-year all-cause
mortality. In Chapter 4, we identify the ranking of predictors and select the best-
performed prediction model for 5-year mortality. In Chapter 5.1 we discuss our
competing risk analysis and in Chapter 5.2 we introduce a bootstrap method we
used to assess the impact of sample size on the power of regression coefficients for
competing risk model, and report the our simulation results. In Chapter 6 we intro-





Originally, there are 14,631 participants in NHANES 2003-2004 and 2005-2006
cohort. We excluded participants who: 1) were younger than 50 y.o. or older than
85 y.o. at the time they wore the accelerometer (9369 participants) 2) had fewer
than 3 days of valid data, either due to less than 10 hours of estimated wear time
or due to either of the two NHANES provided quality flags indicate data quality
concerns (1832 participants) 3) were ineligible for mortality follow-up due to in-
sufficient identifying data to create a National Death Index submission record (6
participants) 4) died from accidents (8 participants) 5) were alive, but had a follow
up less than 5 years or died after 5 years (183 participants) 6) who did not have the
cause of death available (1 participant) or 7) had missing any of the demographic
predictor variables we adjust for (261 participants). Eventually, there were 2971
participants from the NHANES 2003-2004 and 2005-2006 cohorts for my analysis.
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The accelerometer data are originally in long format, with one row per subject-
minute. Using the data package(nhanesdata)[7] we transformed the accelerometer
data into the standard 1440+ format. In this format each row corresponds to per
subject-day and each cell corresponding to minute-level activity count. Figure 1
displays an example of the processed accelerometer data format. We have also
created a data matrix of non-wear flags using established algorithms to account
for the non-wear time [10]. The data matrix is also in the 1440+ format, and each
cell contains a binary outcome with 1 flagged for non-wear and 0 flagged for wear.
Wear/non-wear flags were estimated from the data using the standard NHANES
algorithms.
Starting from the processed accelerometer data and the flag data matrix, we
have derived the activity metrics using the procedure listed in Table 1. Suppose
that i=1, 2, ..., N denotes number of subjects and j=1, 2, ..., M denotes the number
of days for each subject, and t=1, 2, ..., 1440 denotes minutes on each subject-day.
Let ACijt be the activity count for subject i on day j minute t, and Zijtbe the non-












The cut-point for sedentary time is set to be 100 and the cut-point for moderate-
to-vigorous(MVPA) activity is set to be 2020. That is, any minute with activity
count above 2020 is accumulated into MVPA time and any minute with activity
5
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Figure 2.1: Example of the processed accelerometer data format
SEQN MIN1 MIN2 MIN3 . . . . . . MIN1440
1 21009 0 0 0 . . . . . . 0
2 21009 0 0 0 . . . . . . 0
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
7 21009 0 0 0 . . . . . . 0
772 21868 0 0 0 . . . . . . 0
773 21868 0 0 0 . . . . . . 0
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
778 21868 0 0 0 . . . . . . 0
6
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count below 100 is accumulated into sedentary time.
For fragmentation metrics, we will introduce a different system of notation.
Let DA denote the duration of the longest active bout, nA(t) denote the number
of bouts of length t, and ncA(t) denote the number of active bouts of length ≤ t.
Then the total active time can be represented as TA = ∑
DA
t=1 nA(t) ∗ t, and the total
number of active bouts can be represented as nA = ∑
DA
t=1 nA(t). Notations for














Table 2.1: Activity metrics along with the procedure
used to derive them and their interpretation
Metrics Interpretation Derivation






t=1 log(ACijt + 1)


























wear.timei Average daily wear time for subject i ∑
1440
t=1 (1 − zijk)


























Table 2.1 continued from previous page
h̄A(h̄r) Average Hazard from Active(Sedentary) to Sedentary(Active)
Suppose for observed durations
t1,...,tn, it is assumed that there
are k unique values which are
denoted in increasing order by















where D = tn1 , tn2 , ...tnm






























Table 2.2: Table 2.2 continued from previous page
Metrics Notes
TLACi
Pdaytimei Daytime is defined as 6am-6pm
Sed.Minsi cut-point for sedentary activity is 100




Bounded between 0 and 1. When g is close to 1, it means the total active(sedentary) time is accumulated via a small
number of longer bouts. When g is close to 0, it means all bouts contribute equally to total active(sedentary) time.
h̄A(h̄r) Larger values indicate a higher frequency of transitioning from active(sedentary) to sedentary (active) state.
λA(λS) Larger values indicates more frequent transitioning between active (sedentary) states and sedentary (active) states.
αA(αS)
αA(αS)is the scaling parameter of the power law distribution, which is a distribution commonly used to model
active(sedentary) bout duration. Larger values of,means that the total active(sedentary) time is accumulated via a
larger number of shorter bouts.
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Other demographic, co-morbidity, and lifestyle covariates considered in the
analysis include: Age, Gender (binary), BMI Group (underweight, normal, over-
weight, obese), Race (White, Black, Others), Education (less than high school, high
School, more than high school, missing education), Diabetes (binary), CHF (bi-
nary), CHD (binary), Cancer (binary), Stroke (binary), Smoking Status (current
smoker, never smoker, former smoker), Alcohol (current drinker, never drinker,
former drinker,missing alcohol status), Drinking Status (heavy drinker,moderate
drinker, non-drinker, missing drinking status), Mobility Problem (binary), pulse in
60s (continuous), PulseIrregular (binary), difference in systolic blood pressure and
diastolic blood pressure (continuous), Framingham Score (continuous) derived us-
ing information including age, gender, systolic blood pressure, current smoker or
not, diabetes or not, total cholesterol, HDL-cholesterol, and blood pressure treated
with medicine or not [4]. Of the participants included in our analysis, 2652 were
alive after 5 years and 319 were deceased within 5 years. Table 2 compares the
survey weights adjusted or unadjusted population characteristics between indi-
viduals who were alive and who were deceased within 5 years. Table 2 indicates
that population characteristics adjusted for survey weights differ significantly be-
tween individuals who were alive and individuals who were deceased. We used
a size of the test equal to α = 0.05 level. The only variables that were not sta-
tistically different were race (p-value=0.1), and heart rate in 60s (p-value=0.107).
Percent daytime activity is borderline significantly higher among alive individuals
11
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(p-value=0.049). While the summary statistics from the survey weight adjusted
analysis and unadjusted analysis are pretty consistent with each other, there are
discrepancies for specific characteristics such as race, and percent daytime activity.
The unadjusted analysis suggests that there are significantly higher proportion of
white and a lower proportion of black individuals among the deceased individ-
uals (p-value=0.001), and there is not enough evidence that the percent daytime
activity differs between the alive and deceased individuals (p-value=0.136). These
discrepancies may indicate the importance in incorporating survey weights into














Table 2.3: Comparison between survey weight ad-
justed/unadjusted population characteristics between
individuals who were alive and individuals who were
deceased within 5 years. Values in the table represent
n(%) for categorical variables and mean(sd) for contin-
uous variables
Alive Dead p Alive Dead p
n 2652 319 2695.2 275.8
Gender = 1 1291 (48.7) 207 (64.9) <0.001 1214.4 (45.1) 152.5 (55.3) 0.013
BMI category <0.001 0.026
<18.5 23 (0.9) 9 (2.8) 28.7 (1.1) 8.6 (3.1)
18.5-24.99 656 (24.7) 106 (33.2) 718.2 (26.6) 92.3 (33.5)














Table 2.3 continued from previous page
>30 962 (36.3) 95 (29.8) 930.8 (34.5) 83.3 (30.2)
Race 0.001 0.1
White 1527 (57.6) 216 (67.7) 2153.1 (79.9) 231.1 (83.8)
Black 497 (18.7) 54 (16.9) 257.5 (9.6) 25.7 (9.3)
Other 628 (23.7) 49 (15.4) 284.6 (10.6) 19.1 (6.9)
Education <0.001 <0.001
LessThanHS 800 (30.2) 135 (42.3) 506.1 (18.8) 95.8 (34.7)
High school 656 (24.7) 85 (26.6) 719.8 (26.7) 82.4 (29.9)
MoreThanHS 1196 (45.1) 99 (31.0) 1469.3 (54.5) 97.7 (35.4)
Diabetes = 1 431 (16.3) 84 (26.3) <0.001 339.8 (12.6) 66.1 (24.0) <0.001
CHF = 1 107 (4.0) 55 (17.2) <0.001 97.5 (3.6) 53.4 (19.4) <0.001
CHD = 1 184 (6.9) 50 (15.7) <0.001 181.7 (6.7) 44.9 (16.3) <0.001














Table 2.3 continued from previous page
Stroke = 1 127 (4.8) 47 (14.7) <0.001 105.7 (3.9) 43.5 (15.8) <0.001
SmokeCigs <0.001 <0.001
Current 445 (16.8) 79 (24.8) 440.4 (16.3) 62.3 (22.6)
Former 967 (36.5) 145 (45.5) 966.5 (35.9) 130.3 (47.3)
Never 1240 (46.8) 95 (29.8) 1288.3 (47.8) 83.2 (30.2)
Alcohol <0.001 <0.001
Current 1490 (56.2) 133 (41.7) 1638.9 (60.8) 112.3 (40.7)
Former 700 (26.4) 125 (39.2) 609.4 (22.6) 108.3 (39.3)
MissingAlcohol 78 (2.9) 13 (4.1) 78.0 (2.9) 12.0 (4.3)
Never 384 (14.5) 48 (15.0) 368.9 (13.7) 43.2 (15.7)
DrinkStatus <0.001 <0.001
HeavyDrinker 151 (5.7) 28 (8.8) 180.2 (6.7) 25.2 (9.1)














Table 2.3 continued from previous page
ModerateDrinker 1338 (50.5) 105 (32.9) 1458.3 (54.1) 87.1 (31.6)
Non-Drinker 1084 (40.9) 173 (54.2) 978.3 (36.3) 151.5 (54.9)
MobilityProblem = 1 463 (17.5) 97 (30.4) <0.001 424.7 (15.8) 88.0 (31.9) <0.001
Pulse_irregular = 1 187 (7.1) 46 (14.4) <0.001 186.4 (6.9) 37.6 (13.6) 0.001
Age 64.66 (9.14) 73.21 (8.96) <0.001 63.12 (9.70) 73.71 (9.73) <0.001
Pdaytime 75.49 (10.34) 74.57 (11.14) 0.136 75.19 (10.09) 73.83 (11.28) 0.049
TLAC 2811.59 (713.48) 2235.97 (757.64) <0.001 2842.70 (693.60) 2214.02 (778.92) <0.001
Sed_Mins_norm 60.94 (11.86) 71.05 (13.10) <0.001 60.68 (11.50) 71.72 (12.76) <0.001
MVPA_Mins_norm 1.68 (1.99) 0.71 (1.30) <0.001 1.80 (2.03) 0.69 (1.38) <0.001
µS 6.56 (2.75) 9.07 (6.24) <0.001 6.48 (2.63) 9.38 (6.82) <0.001
µA 3.89 (1.31) 3.07 (1.12) <0.001 3.91 (1.29) 3.03 (1.06) <0.001
λS 0.17 (0.05) 0.14 (0.06) <0.001 0.17 (0.05) 0.13 (0.06) <0.001














Table 2.3 continued from previous page
h̄S 0.17 (0.04) 0.15 (0.04) <0.001 0.17 (0.04) 0.15 (0.04) <0.001
h̄A 0.27 (0.08) 0.36 (0.12) <0.001 0.27 (0.08) 0.36 (0.12) <0.001
gS 0.62 (0.05) 0.64 (0.05) <0.001 0.62 (0.05) 0.65 (0.05) <0.001
gA 0.50 (0.07) 0.45 (0.08) <0.001 0.50 (0.06) 0.44 (0.08) <0.001
αA 1.65 (0.08) 1.72 (0.11) <0.001 1.65 (0.08) 1.73 (0.10) <0.001
αS 1.57 (0.07) 1.52 (0.08) <0.001 1.57 (0.07) 1.52 (0.08) <0.001
systolic_ave 132.86 (20.65) 138.02 (26.07) <0.001 131.24 (20.07) 137.78 (26.74) 0.001
diastolic_ave 70.41 (14.02) 65.18 (16.01) <0.001 70.93 (13.82) 64.52 (16.38) <0.001
Blood pressure diff 62.44 (22.13) 72.84 (25.69) <0.001 60.31 (21.80) 73.26 (26.86) <0.001
60sec pulse 70.01 (12.09) 71.45 (13.61) 0.047 69.99 (11.92) 71.21 (13.26) 0.107




To begin, we investigate the association between activity levels and mortality,
exploratory analysis was conducted on the minute-level activity count data. We
first computed the average minute-level activity count across days within subject.
We then subsetted the data based on mortality status, and computed the mean
activity count across subjects among those who were alive and those who were
deceased after 5 years. Figure 3.1 displays the mean activity count trajectory in
the two mortality groups. The black line denotes mean activity count trajectory
among alive individuals, and the red line denotes mean activity count trajectory
among deceased individuals. The figure indicates a visible difference between the
activity trajectory of alive and deceased individuals. The alive individuals tend to
have much higher average activity level, especially between 6am and 8pm.
Figure 3.2 displays the density distributions of the continuous variables, includ-
18
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ing Age, Percent daytime activity (Pdaytime), Total Log Activity Count (TLAC),Sedentary
Minutes normalized by the total wear time (Sed_Mins_norm), Moderate-to-Vigorous-
Activity time normalized by the total wear time (MVPA_Mins_norm), the 10 frag-
mentation metrics, difference in systolic and diastolic blood pressure (BP diff),
Pulse (heart rate) 60s,and Framingham Score, based on mortality status. From
the plot, we noticed apparent shift in the density distribution of all the continuous
variables, except for Pdaytime and Pulse 60s. For subjects who were alive, they
tend to be younger, with higher TLAC, with less time spent in sedentary activi-
ties, more time spent in Moderate-to-Vigorous activities, shorter average sedentary
bouts duration (µS), longer average active bouts duration (µA), higher average haz-
ard of changing from being active to being sedentary (h̄A), higher transition proba-
bility of changing from being active to being sedentary (λA), lower average hazard
of changing from being sedentary to being active (h̄S, lower transition probability
from changing from being sedentary to being active (λS), less fragmented active
time (gA, αA), more fragmented sedentary time (gS, αS), with a smaller difference
between systolic and diastolic blood pressure, and a lower Framingham Score. The
two-sided Wilcoxon Rank Sum Test further confirmed that the differences on the
variables mentioned above are significant(p-value<0.001).
Figure 3.3 displays the correlation between the continuous variables. The cor-
relations between Pdaytime and other activity related covariates are weak. There
was a strong negative correlation between TLAC and Sed_Mins_norm, µS, λA, h̄A,
20
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and αA; Sed_Mins_norm and µA, λS,h̄S,gA, and αS ; µ and λ when the subscripts
are the same; µ and α when the subscripts are the same; µ and h̄ when the sub-
scripts are the same; λ and g when the subscripts are the same; h̄A and gA; gA and
αA. The directions of correlations between fragmentation metrics are consistent
with what those reported in Junrui et. al [5]. This plot suggests that the high corre-
lations between activity need to be taken into account during the variable selection
process, which will be discussed later in section 4.
21
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Figure 3.4 explores the potential interactions between TLAC and age as predic-
tors of 5-year mortality. The colored lines display the smoothed observed prob-
ability of mortality versus age, stratified by different TLAC groups. TLAC was
grouped based on quantiles, and they were clustered into 3 groups to denote <1st
quantile, 1st to 3rd quantile, and >=3rd quantile. The smoothing is done using
the generalized additive model (GAM) implemented in the ‘mgcv‘ package[11].
The plot indicates that there may be a different relationship between mortality and
age as a function of TLAC. Before age 65 being above the third quartile of TLAC
or being between the first and third quartiles of TLAC does not make a large dif-
ference in the estimated trend of association between the probability of mortal-
ity by age. However, after age 65 the mortality probability for individuals with a
TLAC between the first and third quartile is higher than for individuals with TLAC
above the third quartile. The difference between the probability of mortality of in-
dividuals with TLAC above the third quartile and those with TLAC below the first
quartile also increases substantially after age 65. This indicates that there may be








In this chapter we are interested in predictors of mortality in terms of their ab-
solute and relative performance. First, we considered univariate logistic regression
models with 5-year mortality as the outcome, and the activity metrics in Table 2.1,
age, gender, race, education, BMI, mobility problem, CHF, diabetes, stroke, CHD,
drinking status, alcohol status, smoking status, difference in systolic and diastolic
blood pressure (BP Diff), pulse in 60s, PulseIrregular, and the Framingham Score
as the predictor candidates. Each variable is ranked based on the 10-fold cross-
validated area under receiver operation characteristics curve (AUC). Individual
predictors ranking along with their estimated coefficient, t-statistics, and P-values
for the univariate logistic regression model are listed in table 4.1. Table 4.1 indi-
26
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cates that Age is the predictor that maximizes the cross-validated AUC (0.745),
followed by three accelerometry-derived activity metrics: MVPA_Mins_norm, λA,
and µA (AUC=0.725, 0.724,0.724, respectively). The absolute t-statistics for λA, h̄A,
gA, Sed_Mins_norm, and αA are comparable to the t-statistic for the Age effect.
Table 4.1: Ranking of individual mortality predictors
based on 10 cross-validated AUC
Variable Coef t stat P-value AUC
Age 0.103 14.113 0.000 0.745
MVPA_Mins_norm -0.578 -8.289 0.000 0.725
λA 8.896 13.961 0.000 0.724
µA -0.838 -11.221 0.000 0.724
h̄A 8.262 13.964 0.000 0.722
gA -12.176 -13.233 0.000 0.722
Sed_Mins_norm 0.074 13.194 0.000 0.720
αA 8.805 13.330 0.000 0.713
TLAC -0.001 -12.613 0.000 0.712
λS -13.209 -10.325 0.000 0.678
µS 0.172 9.989 0.000 0.676
αS -9.555 -10.707 0.000 0.671
h̄S -12.978 -7.554 0.000 0.642
27
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Table 4.1 continued from previous page
BP Diff 0.017 7.428 0.000 0.627
gS 7.483 6.549 0.000 0.609
Framingham Score 0.022 7.486 0.000 0.566
Smoking Status
Former Smoker -0.169 -1.117 0.264 0.565
Never Smoker -0.840 -5.188 0.000 0.565
Drinking Status
MissingAlcohol -0.119 -0.329 0.742 0.559
Moderate Drinker -0.860 -3.749 0.000 0.559
Non-Drinker -0.150 -0.678 0.498 0.559
Alcohol Status
Former Drinker 0.693 5.224 0.000 0.558
MissingAlcohol 0.624 1.995 0.046 0.558
Never Drinker 0.337 1.893 0.058 0.558
Gender 0.667 5.398 0.000 0.558
Education
High School -0.264 -1.783 0.075 0.551
MoreThanHS -0.712 -5.088 0.000 0.551
CHF 1.600 8.988 0.000 0.535
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Table 4.1 continued from previous page
MobilityProblem 0.726 5.495 0.000 0.534
Race
Black -0.264 -1.642 0.101 0.527
Other -0.595 -3.602 0.000 0.527
BMI Category
18.5-24.99 -0.884 -2.174 0.030 0.526
25-29.99 -1.289 -3.176 0.001 0.526
>30 -1.377 -3.378 0.001 0.526
Diabetes 0.611 4.440 0.000 0.521
Pulse 60s 0.009 1.986 0.047 0.520
Cancer 0.699 4.948 0.000 0.516
CHD 0.914 5.314 0.000 0.514
Pdaytime -0.008 -1.491 0.136 0.510
Stroke 1.234 6.771 0.000 0.508
Pulse Irregular 0.798 4.521 0.000 0.500
After conducting univariate regressions, we conducted forward selection on
three subsets of mortality predictors: non-activity related metrics (age, gender,
race, education, BMI, mobility problem, CHF, diabetes, stroke, CHD, drinking
status, alcohol status, smoking status, BP Diff, pulse in 60s, PulseIrregular, and
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Framingham Score), activity metrics (as shown in table 2.1), and the combination
of non-activity and activity metrics. We started by conducting forward selection
based on non-activity related metrics and chose a benchmark model. The bench-
mark model was then used in a new forward selection procedure for activity met-
rics. Mortality predictors were added to the logistic regression model one at a time.
At each step, each variable that is not already in the model is tested for inclusion
in the model. The variable that maximizes the cross-validated AUC (or minimized
the Akaike’s Information Criteria (AIC) or the Effective Parsimony Information
Criterion(EPIC)) is added to the model. To choose the benchmark model, we in-
cluded all predictors that increased AUC (or decreased AIC/EPIC). EPIC and AIC
are both Maximum Likelihood Estimate driven, however, EPIC penalizes free pa-
rameter more than AIC[8]. Therefore, AIC is less stringent than EPIC, and tends
to accept more covariates into the model. Interestingly, the AUC-based criteria in-
cluded more covariates in the benchmark model than both EPIC and AIC. When
we conducted forward selection of non-activity related covariates, EPIC resulted
in a model with 10 covariates, in the following order of Age: Smoking Status, CHF,
Drinking Status, Gender, Pulse 60s, Diabetes, Stroke, Cancer, and Blood Pressure
difference. AIC resulted in a model with 12 covariates, and also included Mobility
Problem and BMI category in addition to those selected by EPIC. The AUC-based
criterion resulted in a model with 13 covariates, and included CHD in addition to
those selected by AIC. However, the AUC gain is quite small after including the
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11th variable, and CHD is not significant when fitting the model (p-value=0.821).
Therefore, we do not choose our benchmark model based on AUC.
To account for the high correlation between activity metrics, which we ob-
served in Figure 3.3, we included an additional during the forward selection of
activity metrics. Whenever an activity metric is selected as the predictor that max-
imizes the cross-validated AUC (or minimizes AIC/EPIC), the activity metric that
are highly correlated with the selected activity metric (absolute correlation> 0.6)
are excluded from the candidate variable set. For example, if h̄A is selected as the
variable that maximizes the AUC (or minimizes AIC/EPIC), after h̄A is added to
the model, all the activity metrics that have absolute correlation with h̄A greater
than 0.6, including TLAC(corr=-0.73), Sed_Mins_norm(corr=0.76), µA (corr=-0.76),
λA (corr=0.92), gA (corr=-0.9), αA (corr=0.85), are no longer considered as candi-
date predictors and are excluded from the forward selection process.
Based on the three subsets of mortality predictors, we chose three correspond-
ing benchmark models based on EPIC, and the ROC curves for the three bench-
mark models were shown in Figure 4.1. The plots display each of the ROC curves
for the 10 sub-samples from the cross-validation and gives their mean AUC. The
mean ROC curves are shown in red. Model 1 was chosen based only on non-
activity metrics and contains the following predictors: Age, Smoking Status, CHF,
Drinking Status, Gender, pulse in 60s, Diabetes, Stroke, Cancer, and BP differ-




deviation for ease of interpretation. Table 4.2 indicates that the probability of 5
year mortality increases significantly with age, CHF, Cancer, being male, blood
pressure difference, and average hazard from active to sedentary and decreases
significantly if former smoker, never smoker, and moderate drinker. we estimate
that the relative odds of mortality comparing an individual with CHF at baseline
to an individual without CHF at baseline is exp(0.902)= 2.465 (95% CI:1.515, 4.011),
the relative odds of mortality comparing males to females is exp(0.649)=1.914 (95%
CI:1.314,2.786), and the relative odds of mortality comparing an individual with
cancer at baseline to individual without cancer at baseline is exp(0.405)= 1.500
(95% CI:1.056, 2.130). For individuals with the same smoking status, CHF sta-
tus, drinking status, gender, diabetes status, cancer status, pulse within 60s, blood
pressure difference, and h̄A, a 1 year increase in age is associated with 9.9% in-
crease in the odds of mortality; for individuals with the same age, smoking status,
CHF status, drinking status, gender, diabetes status,cancer status, pulse within
60s, and h̄A, 1 unit increase in blood pressure difference is associated with 0.5%
increase in the odds of mortality. FOr individuals of the same age, smoking status,
CHF status, drinking status, gender, diabetes status, cancer status, pulse within
60s, and blood pressure difference, a 1 unit increase in standardized h̄A is associ-
ated with 66.9% increase in odds of mortality. we estimate that the relative odds
of mortality comparing former smoker with current smoker is exp(-0.745)= 0.474
(95% CI:0.279 0.807), the relative odds of mortality comparing never smoker with
33
CHAPTER 4. PREDICTIONS
current smoker is exp(-1.185)= 0.305 (95% CI:0.214,0.437), and the relative odds of
mortality comparing moderate drinker with heavy drinker is exp(-0.922)= 0.398
(95% CI:0.203, 0.780). The Hosmer-Lemeshow goodness of fit test suggests lack of
evidence against the null that the observed number of events is inconsistent with
the predicted number of events (p-value=0.156).
In order to test for potential interactions between TLAC and age as predic-
tors of 5-year mortality, we fitted a separate logistic regression model with 5-year
mortality as the outcome, TLAC along with the non-activity covariates selected in
Model 1 as the predictors. We employed likelihood ratio test to examine whether
the interaction term between TLAC and Age significantly improve model fitting.
However, after accounting for the other covariates the χ2 test statistics failed to




Table 4.2: Estimated coefficients in the final,survey weighted, 8 predictors model
Estimate Std. Error P-value
Age 0.094 0.011 0.000 ***
Smoking Status
Former Smoker -0.745 0.271 0.014 *
Never Smoker -1.185 0.182 0.000 ***
CHF 0.902 0.248 0.002 **
Drinking Status
MissingAlcohol -0.209 0.480 0.670
Moderate Drinker -0.922 0.344 0.016 *
Non-Drinker -0.281 0.362 0.449
Gender 0.649 0.192 0.004 **
pulse 60s 0.010 0.005 0.070 .
Diabetes 0.347 0.212 0.121
Stroke 0.318 0.287 0.283
Cancer 0.405 0.179 0.038 *
BP diff 0.005 0.002 0.044 *
h̄A 0.512 0.088 0.000 ***
Note: ∗p<0.05; ∗∗p<0.01; ∗∗∗p<0.001
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Survival Analysis and Competing
Risk Model
We are also interested in assessing the effect of mortality predictors we selected
in the previous forward selection process on heart disease and cancer related 5-
year mortality, in addition to 5-year all cause mortality. In NHANES, individuals
are also subject to other causes of death, including chronic lower respiratory dis-
eases, Alzheimer disease, Diabetes and so on. Table 5.1 shows the 5-year mortality
by cause of death. Among the individuals who are deceased within 5 years, 22.9%
of deaths are due to heart disease, 28.3% are due to cancer, and 48.8% are due to
causes other than heart disease and cancer. Here, death due to cancer and other
causes are treated as competing events when heart disease related death is the out-
come of interest. The idea is that as an individual who dies of a non-cardiovascular
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Table 5.1: Summary of 5-year mortality by causes of death.
Cause of Death n(%)
Heart Disease 73(22.9)
Cancer 90 (28.2)




Influenza and pneumonia 7(2.2)
Nephritis, nephrotic syndrome and nephrosis 8(2.5)
All other causes (residual) 90(28.2)
Total 319(100)
cause cannot die of heart disease. And similarly, death due to heart disease and
other causes are treated as competing events when cancer related death is the out-
come of interest.
Competing risk analysis is often used to analyze data that contains competing
events. A common estimation approach is to estimate separately the probability
of death for each type of event based on Kaplan-Meier(KM) product limit method.
In this case, the other competing events are treated as censoring variables in ad-
dition to the times censored by withdrawal from the study or loss to follow-up.
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For example, if the heart disease related death is the outcome of interest, we treat
death due to all other causes as censoring, then apply the KM method to estimate
the probability of death due to heart disease at each time point, as in standard
survival analysis setting. This method of estimating event probabilities is called
cause-specific hazard function,and can be expressed as:
λj(t) = limdt→0+
P(t ≤ T ≤ t + dt, π = j|T ≥ t)
dt
,
where T denotes time to death, π denotes cause of death, and π = 1, 2, 3 denotes
death due to heart disease, death due to cancer, and death due to other causes in
our setting.
Once this is done, we can investigate the association between the cause-specific
hazard function and risk factors by modeling the cause-specific hazard function
using, for example, the Cox proportional hazard model:
λj(t; z) = λj0(t)exp(zβ j)
However, as the cause-specific hazards model models hazard in the presence
of competing risks, it may not provide causal interpretation for treatment or risk
factors. An alternative method is based on cumulative incidence function, which
is defined as




Here S(t) denotes the overall survival function at time t that can be estimated using
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the standard KM estimato, and λj(t) is the hazard for death due to cause j at time t,
and can be estimated nonparametrically by
dj(t)
n(t)
where dj(t) denotes the number of
deaths due to cause j at time t and n(t) denotes the total number of observations at
risk at time t. Then regression analysis can be done on the sub-distribution hazard




log(1− Fj(t)) = limdt→0+
P(t ≤ T ≤ t + dt, π = j|T ≥ t ∪ (T ≤ t ∩ π 6= j))
dt
.
The sub-distribution model can be expressed in the similar form as the cox regres-
sion model:
λj(t; z) = λj0(t)exp(zβ j)
[6]
However, the sub-distribution hazard is hard to interpret as it is unnatural.
From the mathematical form of sub-distribution hazard, we can see that subjects
who have already experienced a competing event remain in the risk set, although
they are no longer at risk for the outcome of interest.
5.1 Model Fitting
We fit both cause-specific hazard model and sub-distribution hazard models
to investigate the relative effects of predictors on mortality. We use the predictors
that were selected for 5-year all-cause mortality and use them for heart disease and
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cancer related 5-year mortality. Figure 5.2 displays the estimated hazard ratio with
their 95% confidence intervals from the Cox proportional hazard model for 5-year
all-cause mortality (All-cause mortality), cause-specific hazard model for heart dis-
ease related death (Heart Disease CSHM), and cause-specific hazard model when
cancer related death is the outcome of interest (Cancer CSHM). We also display the
sub-distribution hazard model for heart disease related death (Heart Disease SHM)
and the sub-distribution hazard model for cancer related death (Cancer SHM). The
Cox proportional hazard model for 5-year all cause mortality (red line) indicates
that age, being diagnosed with CHF or cancer at baseline, being male, pulse 60s,
blood pressure difference, and h̄A significantly increase the all-cause mortality haz-
ard. Being a former smoker, never smoker, and moderate drinker are significantly
associated with decreasing the hazard for 5-year all cause mortality. The results
are, in general, consistent with those from the survey-weighted logistic regression
model, which we discussed in Chapter 4. When heart disease related death is the
outcome of interest, moderate drinking, pulse 60s and cancer are no longer statis-
tically significant. When cancer related death is the outcome of interest, CHF and
blood pressure difference no longer reach statistical significance. The change in
the statistical significance may simply be due to a loss of power given the smaller
number of events and should not be necessarily interpreted as the evidence that
these predictors are no longer important.
In addition, quitting smoking has much stronger effect in terms of risk reduc-
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tion for heart disease related death compared with the risk for all-cause mortality.
If all the other risk factors stay the same, the hazard for a former smoker to die due
to heart disease is 0.254 relative to a current smoker (95% CI 0.138,9.468) according
to Heart CSHM, and 0.272 (95%CI:0.15, 0.493) according to Heart SHM, while the
hazard for a former smoker to die from any cause is 0.496 (95% CI:0.37, 0.666) rela-
tive to a current smoker. Therefore, quitting smoking reduces the risk for mortality,
though it has a stronger effect on reducing the mortality risk from heart disease. In-
terestingly, the direction of the effect of moderate drinking and non-drinking flips
when heart disease related death is the outcome of interest. However, this should
not be over-interpreted as results are not statistically significant. This is largely
due to the increased standard error of the estimate. Being male is associated with
a much higher risk for heart disease related death, as the hazard for a male to die
from heart disease is 2.52 (95%CI: 1.486, 4.272) according to Heart CSHM or 2.378
(95%CI:1.422, 3.975) according to Heart SHM, relative to the hazard for a female
if all the other risk factors stay the same. However, the hazard for a male to die
from any cause is 1.798 relative to that for a female (95%CI: 1.405, 2.301). Being
diagnosed with CHF at baseline has much stronger effect in increasing the risk for
heart disease related death [hazard ratio estimated from Heart CSHM: 2.843 (95%
CI:1.536, 5.262) and hazard ratio estimated from Heart SHM: 2.411 (95%CI:1.247,
4.661)]. Being diagnosed with cancer at baseline has a much stronger effect on
increasing the risk for cancer related death [hazard ratio estimated from Cancer
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CSHM: 2.897 (95% CI:1.859, 4.516) and hazard ratio estimated from Cancer SHM:
2.887 (95%CI:1.82, 4.579)]. This makes sense as individuals who are diagnosed at
baseline with a particular disease are more likely to die due to that particular dis-
ease. h̄A has comparable effect on increasing risk for heart-disease related death,
cancer related death, and all-cause mortality, although its effect is stronger when
all-cause mortality is of concern.
Overall, the cause-specific hazard model and sub-distribution hazard model
yield consistent results in terms of the direction and significance of the regression
coefficients. However, the estimated effects of the regression coefficients tend to
be larger when using the cause-specific hazard model. In addition, we noticed
that the standard error for the estimated hazard ratio from Cancer CSHM, Cancer
SHM, Heart Disease CSHM, and Heart Disease SHM are in general larger than
those from the Cox Proportional Hazard Model with all-cause mortality as the
outcome of interest. This is largely due to the reduction in number of primary
events when we restrict to only one cause-specific death.
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5.2 Simulation
Austin et. al [1] concluded that an adequate number of primary events is re-
quired to accurately estimate the regression coefficients in the sub-distribution haz-
ard model. In general, 40 to 50 events per variable (EPV) were necessary to ensure
accuracy. However, when heart disease related death or cancer related death is
the outcome of interest, the EPVs for some categorical variables fail to meet the
40 − 50 criteria. Table 5.3 summarize the EPVs for each variable when heart dis-
ease or cancer related death is the outcome of interest. Table 5.3 indicates that
for heart disease related death there are only 3 events among heavy drinkers, 22
events among moderate drinkers, and 16 events among cancer patients. For cancer
related death there are only 9 events among CHF patients. In the sub-distribution
hazard model for heart disease, moderate drinking and cancer no longer reach sta-
tistical significance though they show significant effects on all-cause mortality. In
the sub-distribution hazard model for cancer, CHF does not reach statistical signif-
icance though it is significant in the all-cause mortality model. This is likely due to
the smaller number of events, which is associated with a reduction in events per
variable (EPV).
We proposed to use the upstrap [3] to examine the effect of EPV on the power
of regression coefficients for the subdistribution hazard model. The detailed steps
are listed as below:
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Table 5.2: EPV for each variable in Heart Disease SHM and Cancer SHM
Events Per Variable(EPV)
Heart Disease SHM Cancer SHM
Age 73 90
Smoking Status
Current Smoker 24 26
Former Smoker 23 45
Never Smoker 26 19
CHF 16 9
Drinking Status
Heavy Drinker 3 11
MissingAlcohol 4 2
Moderate Drinker 22 32
Non-Drinker 44 45
Gender 49 61




BP diff 73 90
h̄A 73 90
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1. Resample the dataset with replacement to 1, 1.5,..., 11 times more of the orig-
inal dataset size
2. For each new resampled data, record the EPV for each variable, then fit the
sub-distribution model for heart disease and cancer, record the p-values for
each covariate, and repeat the process 1000 times for each size of the data
3. Compute the proportion of times p-value≤ 0.05 as well as the mean EPV for
each covariate across the 1000 upstrap samples with each given sample size
The proportion of times p-value≤ 0.05 is the power to detect the effect of a
covariate on the outcome of inteerst. Figure 5.2 and 5.3 display the power curve
for each covariate in the sub-distribution hazard model for heart disease and can-
cer. The x-axis denotes the EPV for each covariate and the y-axis denotes the pro-
portion of times the p-value≤ 0.05. The horizontal red dotted line corresponds
to power=0.6 and the vertical red dotted line corresponds to the EPV that corre-
sponds to power=0.6.
As we expected, the power to detect the significance of each covariate increases
as EPV increases. If we have around 150 events for non-drinking, which corre-
sponds to a sample around 3.5 times larger than the original NHANES sample size,
we will have approximately 60% power to detect the significance of non-drinking
on the sub-distribution hazard for death from heart disease. If we have around
700 events for pulse 60s, which corresponds to a sample around 10 times larger
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than the original NHANES sample size, we will have approximately 60% power
to detect the significance of Pulse 60s on the sub-distribution hazard for death
from heart disease. Similarly, if we have around 400 events for blood pressure
difference, which corresponds to a sample around 4 times larger than the original
NHANES sample size, we will have approximately 60% power to detect the signif-
icance of blood pressure difference on the sub-distribution hazard for death from
cancer. However, we still do not have enough power to detect the significance of
some covariates, such as moderate drinking and baseline cancer status on the the
sub-distribution hazard for death from heart disease, as well as baseline CHF sta-
tus and baseline stroke status on the sub-distribution hazard for death from cancer,
even after expanding the sample to 11 times of the original NHANES sample size.
This provides a new perspective on the sample size that would be necessary to




In order to better visualize the probability of 5 year mortality for individuals
with different risk factors and provide better individualized advice, we made a
shiny APP that can be found at https://yezheng42.shinyapps.io/MortalityCalculator/.
This Shiny APP takes a users age, gender, pulse for 60s, comorbidity informa-
tion including whether the person has CHF, cancer, stroke or diabetes at current
age, blood pressure, self-reported activity percentile among peers, and smoking
and drinking status. Using this information it estimates the predicted probabil-
ity of all-cause mortality within 5 years, as well as the predicted risk relative to
a reference person, who has the same non-modifiable risk factors but has median
activity percentile of his age, is a never smoker and a non-drinker. The prediction
is based on logistic regression that includes Age, gender, CHF, Cancer, Diabetes,
Stroke, smoking status, drinking status, and TLAC as the predictors. The Hosmer-
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Lemeshow goodness of fit test suggests lack of evidence against the null that the
prediction model is not calibrated (p-value=0.602). If the user knows his or her
blood pressure or pulse information, the prediction will take that information into
account and will be built on the extended logistic regression model with further
adjustments for pulse 60s and blood pressure difference. The Hosmer-Lemeshow
goodness of fit test on the extended model also suggests lack of evidence against
the null that the prediction model is not calibrated (p-value=0.165). If the comor-
bidity status is unknown by the user, then the model assumes that she or he does
not have the comorbidity. The regression coefficients are estimated from our anal-
ysis dataset, which has 2971 observations. In these models we used TLAC instead
of h̄A as our activity metric, since it is easier to translate TLAC into activity per-
centile for different age groups. To make the translation, we used the empirical
cumulative density function (CDF) of TLAC for the age group, and imputed the
pth percentile for the age group into the prediction equation. Age groups are de-
fined in 10 year increments starting at 50 and these age groups are only used for
activity; age enters the prediction model as a continuous predictor. For example,
if a 55 year old individual reports her or his activity at the 25th percentile among
their peers, then we apply the following procedure. First, we estimate the empir-
ical CDF of TLAC for the age group between 50 and 60 years of age and estimate
the 0.25 quantile of this distribution. This value is then plugged into the mortality
risk prediction equation. The shiny app allows individuals to adjust their modi-
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fiable health risk factors, including their activity percentile relative to their peers,
smoking status, and drinking status. The software provides immediate feedback





In this thesis, we investigated the associations between participants’ physical
activity, demographic, and health-related characteristics with 5-year all-cause mor-
tality using the data from the NHANES 2003-2004 and 2005-2006. We mainly fo-
cused on older individuals (age between 50-85 y.o.), and we identified that Age,
Smoking Status, CHF, Drinking Status, Gender, Pulse 60s, Diabetes, Stroke, Can-
cer, Blood Pressure difference, and fragmentation metric h̄A are the most predictive
predictors for 5-year all-cause mortality. Together, these risk factors were used to
build a prediction model, which has a 10-fold cross-validated AUC equal to 0.828.
Using the Cox Proportional Hazard Model with 5-year all-indicated that: 1) age,
being diagnosed with CHF or cancer at baseline, being male, having high heart
rate, having high blood pressure difference, and having a higher transition proba-
bility from active to sedentary are significantly associated with increasing the haz-
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ard for 5-year all-cause mortality; and 2) being a former smoker, never smoker, and
moderate drinker are significantly associated with decreasing the hazard for 5-year
all cause mortality. Our competing risk analyses for heart disease and cancer re-
lated deaths supported our findings for all cause mortality and provided further
insights into cause-specific predictors. In particular, moderate drinking, heart rate,
and having cancer were no longer identified as strong predictors of risk of death
from heart disease. Moreover, CHF and having a larger blood pressure difference
were no longer identified as strong predictors of risk of death from cancer. These
findings are most likely due to the decrease in number of events from all cause to
cause specific mortality data. Nevertheless, these findings are consistent with what
we would expect in these scenarios. To get a better idea about the sample sizes at
which various variables would become significantly associated with the hazard
of death we conducted an upstrap re-sampling analysis. In general, the power to
detect the significant effect for each covariate goes up as the sample size and EPV
increases. Our proposed re-sampling method has the potential to estimate sample
size, not only in the competing risk setting, but in any type of analysis regardless
of their complexity. Moreover, we built a Shiny APP to translate our work to the
general public. The APP predicts the probability of all-cause mortality within 5
years, as well as the predicted risk relative to a reference person after user inputs
the required information. Users can also visualize how their predicted probabil-
ity of all-cause mortality can change over time by modifying their modifiable risk
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factors (such as quitting smoking or drinking less or exercising more).
There are some limitations of this study that should be kept in mind when in-
terpreting the results. First, we are using cross-sectional data in NHANES, which
cannot truly be used to infer the effects of changing modifiable risk factors within-
person longitudinally. Information on variables were collected only at baseline
and thus changes in variables (drinking status, blood pressure difference, smoking
status, etc) cannot be analyzed. The prospective data in NHANES comes only from
patients’ mortality status, which are retrieved from the National Death Index. Sec-
ond, some of the information on variables were collected based on self-reported
data, and, thus, misclassification could be a serious problem, which may induce
both bias and measurement error in the predictor variables. Third, as with any
observational study, the problem of residual confounding from variables not mea-
sured in the study or inaccurate measurement or categorization of variables cannot
be ruled out. However, since we have focused primarily on prediction, confound-
ing is less important in this thesis.
The major merits of our study is that the NHANES sample is representative of
the U.S. population and that the sample size is large enough to evaluate a wide
range of mortality risk predictors. Our analysis adds to the body of evidence
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